Furthermore, IFNγ upregulated the expression of several anti-apoptotic proteins, including MCL1, PARP9, and PARP14, both in untreated and imatinib-treated primary human CD34+ CML stem/progenitor cells. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.